Can a patient take naltrexone and Librium (chlordiazepoxide) together?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Naltrexone and Librium (Chlordiazepoxide) Combination

Yes, a patient can take naltrexone and Librium (chlordiazepoxide) together—there are no documented contraindications or significant drug interactions between these medications. However, this combination requires careful clinical consideration based on the specific indication for each medication.

Key Clinical Considerations

No Direct Contraindications

  • Naltrexone-bupropion ER (Contrave) guidelines explicitly list contraindications, which include uncontrolled hypertension, seizure disorders, chronic opioid therapy, and use with MAO inhibitors—but benzodiazepines like chlordiazepoxide are not mentioned as contraindications 1.
  • The FDA-approved safety profile for naltrexone-bupropion ER does not identify benzodiazepines as problematic co-medications 1.

Mechanism and Safety Profile

  • Naltrexone is an opioid receptor antagonist with no abuse potential and mild, transient side effects 2.
  • Chlordiazepoxide is a benzodiazepine that acts on GABA receptors—a completely different mechanism from naltrexone's opioid receptor antagonism 2.
  • These medications work through distinct pharmacological pathways without overlapping mechanisms that would create dangerous interactions 3, 4.

Clinical Context Matters

For Alcohol Dependence:

  • Both medications are used in alcohol dependence treatment, and naltrexone has been studied safely in patients with comorbid psychiatric conditions including depression 5.
  • Chlordiazepoxide is commonly used for alcohol withdrawal management, while naltrexone reduces alcohol craving and relapse risk 3, 4.
  • The combination may actually be clinically appropriate when managing acute alcohol withdrawal (chlordiazepoxide) followed by relapse prevention (naltrexone) 5, 3.

For Obesity Treatment (if using naltrexone-bupropion ER):

  • The primary concern with naltrexone-bupropion ER is the bupropion component, which lowers seizure threshold—benzodiazepines may actually provide some protective effect against seizures 1.
  • Monitor blood pressure and heart rate when using naltrexone-bupropion ER, especially in the first 12 weeks 1.

Important Caveats

Sedation and CNS Depression

  • While not contraindicated, be aware that benzodiazepines cause CNS depression and sedation, which could theoretically be additive with any sedating effects from other medications.
  • Monitor for excessive sedation, particularly during dose titration of either medication.

Psychiatric Monitoring

  • Naltrexone-bupropion ER carries a black box warning for suicidal behavior/ideation in patients younger than 24 years with depression 1.
  • Benzodiazepines can affect mood and cognition—monitor psychiatric symptoms closely when using both medications 1.

Specific to Naltrexone-Bupropion ER

  • Contraindicated with chronic opioid therapy—naltrexone will precipitate withdrawal or block analgesic effects 1.
  • Avoid in uncontrolled hypertension and seizure disorders 1.
  • Reduce dose by half in moderate to severe renal impairment; limit to one tablet daily in moderate to severe hepatic impairment 1.

Practical Recommendations

The combination is safe to prescribe when:

  • The patient requires both medications for legitimate clinical indications (e.g., alcohol withdrawal management transitioning to relapse prevention, or obesity treatment in a patient with anxiety requiring benzodiazepine therapy).
  • The patient is not on chronic opioid therapy 1.
  • Blood pressure is controlled if using naltrexone-bupropion ER 1.
  • No active seizure disorder is present 1.

Monitor for:

  • Excessive sedation or cognitive impairment from the benzodiazepine.
  • Blood pressure and heart rate changes with naltrexone-bupropion ER 1.
  • Emergence of psychiatric symptoms, particularly in younger patients 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Advances in the use of naltrexone: an integration of preclinical and clinical findings.

Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.